Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

  • Joong Won Park
  • , Young Hwan Koh
  • , Hyun Beom Kim
  • , Hwi Young Kim
  • , Sangbu An
  • , Joon Il Choi
  • , Sang Myung Woo
  • , Byung Ho Nam

Research output: Contribution to journalArticlepeer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science